Membranar effects exerted in vitro by polyphenols - quercetin, epigallocatechin gallate and curcumin - on HUVEC and Jurkat cells, relevant for diabetes mellitus

Food and Chemical Toxicology

Volumn 61, Issue , 2013, Pages 86-93

  Margina, Denisa ^a   Gradinaru, Daniela ^a   Manda, Gina ^b   Neagoe, Ionela ^b   Ilie, Mihaela ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

Cardiovascular disease; Diabetes mellitus; Inflammation; Membrane anisotropy; Polyphenols

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CURCUMIN; EPIGALLOCATECHIN GALLATE; GLUCOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYPHENOL DERIVATIVE; QUERCETIN;

ANISOTROPY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE FLUIDITY; CELL MEMBRANE POTENTIAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; T LYMPHOBLAST; UMBILICAL VEIN ENDOTHELIAL CELL;

1-(4-TRIMETHYLAMMONIUMPHENYL)-6-PHENYL-1,3,5-HEXATRIENE P-TOLUENSULFONATE; 3-(4,5-DIMETHYL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE; ADVANCED GLICATION PRODUCTS; AGE; BIS-(1,3-DIBUTYLBARBITURIC ACID)TRIMETHINE OXONOL; BOVINE SERUM ALBUMIN; BSA; C; CARDIOVASCULAR DISEASE; CUMENE HYDROPEROXIDE; CUOOH; CURCUMIN; CVD; DIABETES MELLITUS; DIBAC(4)(3); DIPHENYL-1-PYRENYLPHOSPHINE; DPPP; EGCG; EPIGALLOCATECHIN GALLATE; FBS; FETAL BOVINE SERUM; INFLAMMATION; MEMBRANE ANISOTROPY; MTT; PBS; PHOSPHATE BUFFER SALINE; POLYPHENOLS; Q; QUERCETIN; TMA-DPH;

ANISOTROPY; ANTIOXIDANTS; CATECHIN; CELL MEMBRANE; CELL SURVIVAL; CHEMOKINE CCL2; CURCUMIN; DIABETES MELLITUS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; JURKAT CELLS; LIPID PEROXIDATION; MEMBRANE POTENTIALS; QUERCETIN;

EID: 84888841120     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.02.046     Document Type: Article

References (55)

1. Androutsopoulos V.P., Papakyriakou A., Vourloumis D., Tsatsakis A.M., Spandidos D.A. Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes. Pharmacol. Ther. 2010, 126(1):9-20.
2. Banerjee R., Nageshwari K., Puniyani R.R. The diagnostic relevance of red cell rigidity. Clin. Hemorheol. Microcirc. 1998, 19:21-24.
3. Chen R., Wang J.B., Zhang X.Q., Ren J., Zeng C.M. Green tea polyphenol epigallocatechin-3-gallate (EGCG) induced intermolecular cross-linking of membrane proteins. Arch. Biochem. Biophys. 2011, 507:343-349.
4. Fadel O., Kirat K.E., Morandat S. The natural antioxidant rosmarinic acid spontaneously penetrates membranes to inhibit lipid peroxidation in situ. Biochim. Biophys. Acta 2011, 1808:2973-2980. 10.1016/j.bbamem.2011.08.011.
5. Forbes J.M., Loon Yee L.T., Thallas V., Lassila M., Candido R., Jandeleit-Dahm K.A., Thomas M.C., Burns W.C., Deemer E.K., Thorpe S.R., Cooper M.E., Allen T.J. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 2004, 53:1813-1823.
6. Forsyth A.M., Braunmüller S., Wan J., Franke T., Stone H.A. The effects of membrane cholesterol and simvastatin on red blood cell deformability and ATP release. Microvasc. Res. 2012, 83:347-351.
7. Fraga C.G., Galleano M., Verstraeten S.V., Oteiza P.I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol. Aspects Med. 2010, 31:435-445.
8. Fraga C.G., Oteiza P.I. Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling. Free Radical Biol. Med. 2011, 51:813-823.
9. Fujimoto K., Iwasaki C., Kawaguchi H., Yasugi E., Oshima M. Cell membrane dynamics and the induction of apoptosis by lipid compounds. FEBS Lett. 1999, 446:113-116.
10. Ghosh P.K., Vasanji A., Murugesan G., Eppell S.J., Graham L.M., Fox P.L. Membrane microviscosity regulates endothelial cell motility. Nat. Cell Biol. 2002, 4:894-900.
11. Gomes A., Fernandes E., Lima J.L. Fluorescence probes used for detection of reactive oxygen species. J. Biochem. Biophys. Methods 2005, 65:45-80.
12. Harcourt B.E., Sourris K.C., Coughlan M.T., Walker K.Z., Dougherty S.L., Andrikopoulos S., Morley A.L., Thallas-Bonke V., Chand V., Penfold S.A., de Courten M.P., Thomas M.C., Kingwell B.A., Bierhaus A., Cooper M.E., Courten B., Forbes J.M. Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int. 2011, 80(2):190-198. 10.1038/ki.2011.57.
13. Harvey B.S., Musgrave I.F., Ohlsson K.S., Fransson A., Smid S.D. The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits amyloid-β evoked fibril formation and neuronal cell death in vitro. Food Chem. 2011, 129:1729-1736.
14. Huang S.M., Wu C.H., Yen G.C. Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs. Mol. Nutr. Food Res. 2006, 50(12):1129-1139.
15. Huang Z.J., Haugland R.P. Partition coefficients of fluorescent probes with phospholipid membranes. Biochem. Biophys. Res. Commun. 1991, 181:166-171.
16. Hui Y.Y., McAmis W.C., Baynes J.W., Schaffer R.C., Wolf M.B. Effect of advanced glycation end products on oxidative stress in endothelial cells in culture: a warning on the use of cells studied in serum free media. Diabetologia 2001, 44:1310-1317.
17. Ingolfsson H.I., Koeppe R.E., Andersen O.S. Curcumin is a modulator of bilayer material properties. Biochemistry 2007, 46:10384-10391.
18. Joven J., Rull A., Rodriguez-Gallego E., Camps J., Riera-Borrull M., Hernández-Aguilera A., Martin-Paredero V., Segura-Carretero A., Micol c V., Alonso-Villaverde C., Menéndez J.A. Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolism. Food Chem. Toxicol. 2013, 51:267-279.
19. Jyothirmayi G.N., Modak R., Reddi A.S. L-lysine reduces nonenzymatic glycation of glomerular basement membrane collagen and albuminuria in diabetic rats. Nephron 2001, 87(2):148-154.
20. Karewicza A., Bielska D., Gzyl-Malcher B., Kepczynski M., Lach R., Nowakowska M. Interaction of curcumin with lipid monolayers and liposomal bilayers. Colloids Surf. B: Biointerfaces 2011, 88:231-239.
21. Klapperstück T., Glanz D., Klapperstück M., Wohlrab J. Methodological aspects of measuring absolute values of membrane potential in human cells by flow cytometry. Cytometry A 2009, 75:593-608.
22. Kolodgie F.D., Burke A.P., Nakazawa G., Cheng Q., Xu X., Virmani R. Free cholesterol in atherosclerotic plaques: where does it come from?. Curr. Opin. Lipidol. 2007, 18:500-507.
23. Lakowicz J.R. Principles of Fluorescence Spectroscopy 1999, Kluwer Academic/Plenum, New York. second ed.
24. Ludwig A., Lorenz M., Grimbo N., Steinle F., Meiners S., Bartsch C., Stangl K., Baumann G., Stangl V. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem. Biophys. Res. Commun. 2004, 316:659-665.
25. Margina D., Ilie M., Gradinaru D. Quercetin and epigallocatechin gallate induce in vitro a dose-dependent stiffening and hyperpolarizing effect on the cell membrane of human mononuclear blood cells. Int. J. Mol. Sci. 2012, 13:4839-4859. 10.3390/ijms13044839.
26. Margina D., Ilie M., Manda G., Neagoe I., Mocanu M., Ionescu D., Gradinaru D., Ganea C. Quercetin and epigallocatechin gallate effects on the cell membranes biophysical properties correlate with their antioxidant potential. Gen. Physiol. Biophys. 2012, 31(1):47-55.
27. Martins A.P., Lopes P.A., Martins S.V., Madeira A., Santos N.C., Prates J.A.M., Moura T.F., Soveral G. Conjugated linoleic acid reduces permeability and fluidity of adipose plasma membranes from obese Zucker rats. Biochem. Biophys. Res. Commun. 2010, 398:199-204.
28. Mishra M.K., Ghosh D., Duseja R., Basu A. Antioxidant potential of Minocycline in Japanese Encephalitis Virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem. Int. 2009, 54:464-470.
29. Negrei C., Margina D., Balanescu A., Ilie M., Gliga A., Baconi D.L., Balalau D. Preliminary results regarding certain redox stress parameters and peripheral blood mononuclear cell membrane fluidity for rheumatoid arthritis patients. Rom. Biotechnol. Lett. 2009, 14(3):4436-4442.
30. Okimoto Y., Watanabe A., Niki E., Yamashita T., Noguchi N. A novel fluorescent probe diphenyl-1-pyrenylphosphine to follow lipid peroxidation in cell membranes. FEBS Lett. 2000, 474:137-140.
31. Panicker S.R., Kartha C.C. Curcumin attenuates glucose-induced monocyte chemoattractant protein-1 synthesis in aortic endothelial cells by modulating the NF-κB pathway. Pharmacology 2010, 85(1):18-26.
32. Panicker S.R., Sreenivas P., Babu M.S., Karunagaran D., Kartha C.C. Quercetin attenuates Monocyte Chemoattractant Protein-1 gene expression in glucose primed aortic endothelial cells through NF-κB and AP-1. Pharmacol. Res. 2010, 62(4):328-336.
33. Pebay-Peyroula E., Dufourc E.J., Szabo A.G. Location of diphenyl-hexatriene and trimethylammonium-diphenyl-hexatriene in dipalmitoylphosphatidylcholine bilayers by neutron diffraction. Biophys. Chem. 1994, 53(1-2):45-56.
34. Pendurthi U.R., Williams J.T., Mohan Rao L.V. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-κB. Arterioscl. Throm. Vas. 1997, 17:3406-3413.
35. Perry M.C., Demeule M., Régina A., Moumdjian R., Béliveau R. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Mol. Nutr. Food Res. 2010, 54:1192-1201.
36. Ross R. Atherosclerosis -- an inflammatory disease. N. Engl. J. Med. 1999, 340(2):115-126.
37. Sanders S.K., Crean S.M., Boxer P.A., Kellner D., LaRosa G.J., Hunt S.W. Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J. Immunol. 2000, 165(9):4877-4883.
38. Sergent O., Ekroos K., Lefeuvre-Orfila L., Rissel M., Forsberg G.B., Oscarsson J., Andersson T.B., Lagadic-Gossmann D. Ximelagatran increases membrane fluidity and changes membrane lipid composition in primary human hepatocytes. Toxicol. In Vitro 2009, 23:1305-1310.
39. Sergent O., Pereira M., Belhomme C., Chevanne M., Huc L., Lagadic-Gossmann D. Role for membrane fluidity in ethanol-induced oxidative stress of primary rat hepatocytes. J. Pharmacol. Exp. Ther. 2005, 313:104-111.
40. + channels by curcumin in Jurkat-T cells. J. Pharmacol. Sci. 2011, 115(2):144-154.
41. Sun Y., Lee C.C., Hung W.C., Chen F.Y., Lee M.T., Huang H.W. The bound states of amphipathic drugs in lipid bilayers: study of curcumin. Biophys. J. 2008, 95:2318-2324.
42. Takahashi M., Shibata M., Niki E. Estimation of lipid peroxidation of live cells using a fluorescent probe, diphenyl-1-pyrenylphosphine. Free Radical Biol. Med. 2001, 31:164-174.
43. Thakkar A., Sutaria D., Grandhi B.K., Wang J., Prabhu S. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer. Oncology 2013, 90. (Epub ahead of print).
44. Triantafyllou A., Liakos P., Tsakalof A., Chachami G., Paraskeva E., Molyvdas P.A., Georgatsou E., Simos G., Bonanou S. The flavonoid quercetin induces hypoxia-inducible factor-1α (HIF-1α) and inhibits cell proliferation by depleting intracellular iron. Free Radical Res. 2007, 41(3):342-356.
45. Tribolo S., Lodi F., Connor C., Suri S., Wilson V.G., Taylor M.A., Needs P.A., Kroon P.A., Hughes D.A. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 2008, 197:50-56.
46. Van Aalst J.A., Burmeister W., Fox P.L., Graham L.M. α-Tocopherol preserves endothelial cell migration in the presence of cell-oxidized low-density lipoprotein by inhibiting changes in cell membrane fluidity. J. Vasc. Surg. 2004, 1:229-237.
47. Van Blitterswijk W.J., Van Hoeven R.P., Van Der Meer B.W. Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim. Biophys. Acta 1981, 644:323-332.
48. Vaya A., Martinez Triguero M., Reganon E., Vila V., Martinez Sales V., Sola E., Hernandez Mijares A., Ricart A. Erythrocyte membrane composition in patients with primary hypercholesterolemia. Clin. Hemorheol. Microcirc. 2008, 40:289-294.
49. Veskoukis A.S., Tsatsakis A.M., Kouretas D. Dietary oxidative stress and antioxidant defense with an emphasis on plant extract administration. Cell Stress Chaperon. 2012, 17(1):11-21.
50. Weng C.J., Yen G.C. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev. 2012, 38(1):76-87.
51. Wiggins P., Phillips R. Analytic models for mechanotransduction: gating a mechanosensitive channel. Proc. Natl. Acad. Sci. USA 2004, 101:4071-4076.
52. Wilson W.J., Poellinger L. The dietary flavonoid quercetin modulates HIF-1a activity in endothelial cells. Biochem. Biophys. Res. Commun. 2002, 293:446-450.
53. Winterbone M.S., Tribolo S., Needs P.W., Kroon P.A., Hughes D.A. Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009, 202:431-438.
54. Wu C.H., Yen G.C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J. Agric. Food Chem. 2005, 53(8):3167-3173.
55. Yan S.F., Ramasamy R., Naka Y., Schmidt A.M. Glycation, inflammation, and RAGE. A scaffold for the macrovascular complications of diabetes and beyond. Circulation Res. 2003, 93:1159-1169.